Anthropic’s IPO filing reveals its strategy for keeping enterprise customers hooked

Anthropic is building the same kind of cross-product ecosystem that helped make tech companies like Amazon and Uber enormously sticky, and its S-1 suggests the strategy is working. More than half of customers spending at least $100,000 annually now use both the Claude platform and a first-party app like Claude Code or Cowork, up from about 30% at the end of last year. 

“The speed and depth of our enterprise customer adoption are powerful evidence of Claude’s position at the frontier of AI,” the S-1, filed with the Securities and Exchange Commission on Monday, reads. 

As of September 30, Anthropic recorded more than 11,900 customers spending at least $100,000; more than 1,900 customers spending upwards of $1 million; and about 250 customers spending $10 million or more annually. 

Anthropic attributes customer momentum to a “significant usage expansion as customers realize the value of deploying Claude across their organizations,” which drove net revenue retention of about 900% as of the end of the third quarter. 

Throwing shade at the entire legacy SaaS industry, Anthropic pitches Claude as not a “static product that serves a single use case,” but rather “frontier AI with rapidly advancing capabilities” spanning the models, the developer platform, and the applications users interact with directly. 

“An advance at any layer compounds across all three layers, accelerating the pace at which we can deliver more capable intelligence,” the filing reads, calling this “integrated approach” the reason more customers use both the Claude Platform and first-party apps.

Anthropic also leans on its third-party distribution partnerships with hyperscalers AWS, Google Cloud, and Microsoft Azure. Under what the filing calls a “joint go-to-market approach,” Anthropic holds the direct contractual relationship with customers and pays each cloud provider a fee, which the company says lets it “avoid channel conflict” and “set pricing.”

Customer concentration is another risk. 

View Bio